Literature DB >> 30976451

Severe heatwave in Japan.

Kei Hayashida1, Keiki Shimizu2, Hiroyuki Yokota3.   

Abstract

Entities:  

Year:  2019        PMID: 30976451      PMCID: PMC6442519          DOI: 10.1002/ams2.387

Source DB:  PubMed          Journal:  Acute Med Surg        ISSN: 2052-8817


× No keyword cloud information.
Dear Editor, Despite adequate treatment, heatstroke is often fatal.1 The incidence of heat‐related deaths is increasing with climate change and predicted worldwide increases in the frequency and intensity of heatwaves.2 Between July 14 and July 24, 2018, the maximal and minimal temperatures throughout Japan reached unusual highs accompanied by extreme humidity, leading to a notable surge in victims of heat‐related death nationwide. In fact, Japanese hospitals experienced an unprecedentedly massive admission of heat‐related disorders (particularly heatstroke) and deaths. During this period, the mean wet bulb globe temperature (an index of environmental heat stress) of six fixed‐point observation cities (Tokyo, Osaka, Nagoya, Hiroshima, Niigata, and Fukuoka) reached 30.9–31.5°C. This is believed to be largely responsible for the deadly epidemic of heatstroke (Fig. 1). In the city of Kumagaya, about 40 miles northwest of Tokyo, the mercury reached 106°F (41.1°C) on July 23 – the highest temperature on record in Japan. Within the 11‐day period, there were 34,147 cases of heat‐related emergency transportation throughout Japan, or roughly 64.4% of the 52,984 cases between May and September of 2017. Of the 34,147 cases, approximately 46.8% (n = 15,994) were aged 65 years and above, 2.9% (n = 997) were diagnosed with heatstroke (regarded as the most severe heat‐related illness), and 0.3% (n = 99) were found clinically dead upon the arrival of emergency medical service.3 In response to this catastrophic heatwave, within a few days of the onset of the sharp increase in heat‐related emergency transportations and deaths, the Japanese Association for Acute Medicine issued advisories about the scorching heat, urging people to take measures to avoid heatstroke.4
Figure 1

Total numbers of heat‐related emergency transportations throughout Japan in July 2017 and July 2018. Green and red (plus black) bars indicate the number of patients with heat‐related illness who were transferred by ambulance in July 2017 and July 2018, respectively. Black bar indicates patients with severe heat‐related disorders or cardiac arrest on arrival of emergency medical staff at the scene. Purple line indicates the mean wet globe temperatures of six fixed‐point observation cities in 2018 (Tokyo, Osaka, Nagoya, Hiroshima, Niigata, and Fukuoka).

Total numbers of heat‐related emergency transportations throughout Japan in July 2017 and July 2018. Green and red (plus black) bars indicate the number of patients with heat‐related illness who were transferred by ambulance in July 2017 and July 2018, respectively. Black bar indicates patients with severe heat‐related disorders or cardiac arrest on arrival of emergency medical staff at the scene. Purple line indicates the mean wet globe temperatures of six fixed‐point observation cities in 2018 (Tokyo, Osaka, Nagoya, Hiroshima, Niigata, and Fukuoka). Although no sector of the population is considered exempt from the risks posed by heatwaves, previous research has shown that elderly people (aged >65 years), younger children, individuals with pre‐existing medical conditions, those with low socioeconomic status (e.g., low education, low income, and social isolation), and those with poor access to adequate cooling systems were particularly vulnerable to heat‐related illness. Extrinsic vulnerability factors include certain material conditions (e.g., air conditioning) and urban design (e.g., heat island effect and population density).5 The development of national and regional strategies for reducing the health impacts of heat on vulnerable populations or territories – such as a nationwide campaign or urban environmental improvements – is an urgent public health need. Additionally, further recognition and characterization of heat‐related illness are essential for establishing fundamental evidence of this “preventable” illness.

Disclosure

Approval of the research protocol: N/A. Informed consent: N/A. Registry and the registration no. of the study/trial: N/A. Animal studies: N/A. Conflict of interest: None.
  6 in total

Review 1.  Classic and exertional heatstroke.

Authors:  Abderrezak Bouchama; Bisher Abuyassin; Cynthia Lehe; Orlando Laitano; Ollie Jay; Francis G O'Connor; Lisa R Leon
Journal:  Nat Rev Dis Primers       Date:  2022-02-03       Impact factor: 52.329

2.  COVID-19 pandemic modifies temperature and heat-related illness ambulance transport association in Japan: a nationwide observational study.

Authors:  Xerxes Seposo; Lina Madaniyazi; Chris Fook Sheng Ng; Masahiro Hashizume; Yasushi Honda
Journal:  Environ Health       Date:  2021-12-02       Impact factor: 5.984

Review 3.  [Cardiac arrest under special circumstances].

Authors:  Carsten Lott; Anatolij Truhlář; Anette Alfonzo; Alessandro Barelli; Violeta González-Salvado; Jochen Hinkelbein; Jerry P Nolan; Peter Paal; Gavin D Perkins; Karl-Christian Thies; Joyce Yeung; David A Zideman; Jasmeet Soar
Journal:  Notf Rett Med       Date:  2021-06-10       Impact factor: 0.826

4.  Heat health risk assessment analysing heatstroke patients in Fukuoka City, Japan.

Authors:  Nishat Tasnim Toosty; Aya Hagishima; Ken-Ichi Tanaka
Journal:  PLoS One       Date:  2021-06-21       Impact factor: 3.240

5.  Analysis on Effectiveness of Impact Based Heatwave Warning Considering Severity and Likelihood of Health Impacts in Seoul, Korea.

Authors:  Yeora Chae; Jongchul Park
Journal:  Int J Environ Res Public Health       Date:  2021-03-01       Impact factor: 3.390

6.  COVID-19 and Heat Illness in Tokyo, Japan: Implications for the Summer Olympic and Paralympic Games in 2021.

Authors:  Kazuki Shimizu; Stuart Gilmour; Hiromi Mase; Phuong Mai Le; Ayaka Teshima; Haruka Sakamoto; Shuhei Nomura
Journal:  Int J Environ Res Public Health       Date:  2021-03-31       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.